Texas investigates UnitedHealth Group as UnitedHealth Group stock costs EUR 368.50
Published on 10/27/2026 at 12:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCoverage inquiry and operating metrics
- Texas Attorney General Ken Paxton issued civil investigative demands on October 5, 2026.
- UnitedHealth reported USD 112.7 billion in third-quarter 2026 revenue and a 3.6 percent net margin.
- UnitedHealth Group stock trades at EUR 368.50 at 12:18 p.m. CET at Lang & Schwarz on October 27, 2026, 0.35 percent above the Xetra close of October 26, 2026.
UnitedHealth Group (ISIN US91324P1021) is facing a Texas healthcare investigation over alleged coverage practices, while its third-quarter operating figures show a 3.6 percent net margin. The Office of the Attorney General said on October 5, 2026, that Ken Paxton had issued civil investigative demands to UnitedHealth.
Texas inquiry targets coverage practices
The attorney general said the inquiry concerns alleged deceptive and unlawful practices in administering insurance benefits and making patient-care decisions. The release describes allegations involving prior authorization and coverage determinations, but it does not establish that UnitedHealth violated the law.
For investors, the inquiry adds a regulatory and reputational risk to a business already working to simplify approvals. UnitedHealth said in its third-quarter release that it plans to eliminate 30 percent of current prior approval volume by the end of 2026, linking operational reforms to access and affordability.
What does the earnings cushion show?
UnitedHealth reported USD 112.7 billion in third-quarter 2026 revenue, down from USD 113.2 billion in the third quarter of 2025, while earnings from operations increased to USD 6.6 billion from USD 4.3 billion. The figures come from the Business Wire release dated October 13, 2026.
The same release reported an adjusted earnings outlook of at least USD 20.50 per share for full-year 2026, up from the previous outlook range of USD 19.50 to USD 20.00. Medical care costs remained central: the third-quarter medical care ratio was 88.4 percent, compared with 89.9 percent a year earlier.
Stock holds above the Xetra close
At Lang & Schwarz, UnitedHealth Group stock was trading at EUR 368.50 on October 27, 2026, at 12:18 p.m. CET. That was 0.35 percent above the Xetra close of October 26, 2026, at EUR 367.20.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group at a glance
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 27, 2026, 12:18 p.m. CET): EUR 368.50
- Change versus Xetra close: plus 0.35 percent
- Xetra close (October 26, 2026): EUR 367.20
- 52-week range: EUR 222.70-400.60 (as of October 27, 2026)
Market context: Market report S&P 500.
